Indocid

Basic Indocid Information

• INN (International Nonproprietary Name): Indomethacin (also known as Indometacin in some countries).
• Brand Names Available In Australia: Not specified.
• ATC Code: M01AB01.
• Forms & Dosages: Capsules/tablets 25 mg and 50 mg; sustained‑release 75 mg; oral suspension 25 mg/5 mL (237 mL bottle); suppositories 50 mg and 100 mg; injectable (IV) 1 mg/vial lyophilised for reconstitution.
• Manufacturers In Australia: Not specified (global suppliers include Merck Sharp & Dohme, Iroko Pharmaceuticals, Sun Pharma, Sandoz, Apotex and others).
• Registration Status In Australia: TGA (Australia) is listed among regulatory agencies for the product; classification is prescription only.
• OTC / Rx Classification: Prescription only (Rx) in regulated markets.

Critical Warnings & Restrictions

High‑Risk Groups (Elderly, Pregnancy, Chronic Illness)

Patients often want to know who should avoid indocid immediately.

• Immediate safety: Indomethacin is a potent NSAID with significant gastrointestinal, renal and cardiovascular risks.
• Absolute contraindications: Hypersensitivity to NSAIDs, active gastrointestinal bleeding or peptic ulcer, severe hepatic, renal or cardiac failure, and aspirin/NSAID‑induced asthma.
• Elderly: Start at the lower end of the dose range and monitor closely for GI bleeding, renal decline and fluid retention.
• Pregnancy: Avoid use in pregnancy, particularly in the third trimester due to risk of premature closure of the ductus arteriosus and other foetal effects.
• Breastfeeding: Use with caution; discuss risks and alternatives with a prescriber or pharmacist.
• Other high‑risk patients: People with uncontrolled hypertension, heart failure, chronic kidney disease, cirrhosis, bleeding disorders or a history of peptic ulcer/bleeding.

The checklist below helps pharmacists and prescribers protect patients before supply.

• Monitoring Checklist:
• Baseline renal function (serum creatinine/eGFR).
• Liver function tests if clinically indicated.
• Blood pressure measurement before and during therapy.
• Review concurrent medicines: anticoagulants, SSRIs/SNRIs, lithium, diuretics, ACE inhibitors/ARBs, methotrexate, ciclosporin.
• Document allergy history and prior NSAID reactions.
• Discuss GI protective strategies if long term (e.g. PPI where appropriate).
• Provide written medicine list and counselling to the patient before supply.

Interaction With Activities (Driving, Workplace Safety Under Australian Law)

Many people ask whether indocid affects their ability to drive or work.

Indomethacin can cause dizziness, drowsiness and visual disturbance which may impair driving or operating machinery.

Employers and workers should follow Safe Work Australia guidance when any medicine poses an impairment risk at work.

If you experience symptoms such as dizziness or blurring, do not drive or operate heavy machinery until the effects have worn off.

Report any adverse effects to your GP or pharmacist and consider a workplace risk assessment if impairment affects duties.

Q&A — Can I Drive After Taking It In Australia?

• Short answer: Not if you feel dizzy, drowsy or have blurred vision.
• Driving while impaired can attract legal penalties; always err on the side of safety.
• If in doubt, get specific advice from your prescriber or pharmacist before driving.

Usage Basics

INN, Brand Names Available In Australia

• INN: indomethacin.
• Common Brand Variants: Indocid, Indocin and generic indomethacin formulations are used internationally; local labelling may show Indometacin spelling.
• Packaging & Strengths: International packaging commonly includes 25 mg and 50 mg tablets/capsules, SR 75 mg, oral suspension 25 mg/5 mL (237 mL), suppositories 50–100 mg, and IV 1 mg/vial for reconstitution.

Legal Classification (TGA Approval, PBS Considerations)

• Indomethacin is a prescription‑only medicine in regulated markets and subject to TGA oversight in Australia.
• Availability on the PBS varies by formulation and indication; check the PBS Schedule and local formularies for up‑to‑date subsidy listings.
• Community pharmacies and hospitals supply different formulations depending on indication, and some uses (e.g. neonatal PDA IV use) are hospital‑only.
• Telehealth prescriptions are accepted but PBS subsidy may require specific prescription parameters; pharmacists can advise on PBS eligibility and authority requirements.

Dosing Guide

Standard Regimens

Patients commonly ask what dose to start and how quickly to expect relief.

Typical adult dosing based on product information and international practice is summarised below.

Adjustments For Comorbidities

• Reduce dose in elderly patients and those with renal or hepatic impairment and monitor renal function and blood pressure.
• Avoid indomethacin in severe organ failure where the risk of toxicity and accumulation is high.
• Consider alternative analgesics if there are interacting medicines or high gastrointestinal risk.
• Document a monitoring plan if treatment extends beyond the acute period.

Q&A — What If I Miss A Dose?

• Take the missed dose as soon as you remember unless it is close to the next scheduled dose.
• Do not double up doses to make up for a missed one.
• Contact your pharmacist or GP for advice if you are unsure or frequently miss doses.

Interaction Chart

Food And Drinks (Alcohol, Coffee, Australian Diet Context)

• Alcohol increases the risk of gastrointestinal bleeding while taking indomethacin; minimise alcohol while on therapy.
• Caffeinated drinks do not have a major direct interaction with indomethacin but can worsen gastric irritation in sensitive people.
• Take indomethacin with food or milk to reduce dyspepsia when possible.
• Do not combine with other over‑the‑counter NSAIDs or aspirin for pain relief without medical advice.

Common Drug Conflicts

Always check with a pharmacist before starting new medicines or supplements while taking indomethacin.

User Reports & Trends

What do Australian consumers say when they discuss indocid at the pharmacy counter or online?

Feedback from community review platforms and pharmacy counselling notes commonly highlights short‑term efficacy and tolerability concerns.

• Top 5 Patient Concerns:
• Gastrointestinal upset and heartburn.
• Dizziness and drowsiness affecting driving or work.
• Price sensitivity and comparisons between generics.
• Rural access to specialised forms such as suppositories or IV formulations.

Short anonymised testimonials synthesis:

• “Used for a gout flare and felt pain relief within a few hours, but had nausea the next day.”
• “Pharmacist recommended starting low because of age and blood pressure; holidayed with extra monitoring.”
• “Couldn’t find suppositories locally in a rural town; had to wait for hospital supply.”

Access & Purchase Options

National Chains (Chemist Warehouse, Priceline, TerryWhite Chemmart)

• Community pharmacies dispense indomethacin on a valid prescription and many national chains stock generics or can order specific strengths.
• Pricing varies between chains and PBS subsidy status affects out‑of‑pocket cost.
• Pharmacists provide clinical counselling at supply and will confirm safe use before dispensing.

Online Pharmacies And Telehealth E‑Prescriptions

Online ordering and telehealth are commonly used to obtain prescription medicines in Australia.

• Many accredited Australian online pharmacies accept e‑prescriptions and provide mail delivery; verify pharmacy accreditation before purchase.
• Rural patients commonly use mail delivery or rural pharmacy networks to access specialised forms; hospital IV formulations remain inpatient only.
• Checklist For Safe Online Purchase:
• Confirm the pharmacy is Australian‑based and properly accredited.
• Ensure a valid prescription is required and verified.
• Check e‑prescription acceptance and shipping options for your area.
• Avoid unregulated overseas sellers that do not require prescriptions.

In our online pharmacy, indocid is available without a prescription, with discreet delivery to Australia in 9-21 days.

Mechanism & Pharmacology

Simplified Explanation

Indomethacin belongs to the ATC class M01AB01 of acetic acid derivatives.

It works by inhibiting cyclo‑oxygenase enzymes (COX‑1 and COX‑2), which reduces prostaglandin synthesis and lowers inflammation, pain and fever.

This mechanism explains why indomethacin is effective in acute gout and inflammatory arthritides.

Clinical Terms

• Onset for gout: Pain reduction often occurs within 2–4 hours with continued improvement over 3–5 days.
• Safety profile: Indomethacin has a higher gastrointestinal and renal adverse event profile relative to some other NSAIDs, and risk increases with dose and duration.
• Route considerations: Oral, suppository and IV formulations affect onset and are chosen based on clinical need and patient tolerability.

Suggested simple diagram for a patient leaflet: “COX Inhibition → ↓ Prostaglandins → ↓ Pain & Inflammation; Side Effects → GI, Renal, Cardiovascular” as a single concise flowchart.

Indications & Off‑Label Uses

Approved Indications By TGA (And International Practice)

• Common approved uses include inflammatory arthropathies such as osteoarthritis, rheumatoid arthritis and ankylosing spondylitis.
• Indomethacin is also used for acute gouty arthritis and short courses for pain and inflammation.
• Always confirm current TGA Product Information for Australian‑specific approved indications and dosing.

Off‑Label Uses In Australian Clinical Practice

• Off‑label hospital uses include neonatal patent ductus arteriosus (PDA) closure with IV formulations in specialist settings.
• Specialist paediatric rheumatology may use indomethacin in selected cases under careful monitoring and weight‑based dosing.
• Note: IV and neonatal uses are hospital‑only and managed by specialists.

Key Clinical Findings (Recent Evidence Summary)

What the evidence and practice updates say about indomethacin up to 2026.

Indomethacin is effective for acute gout flares with rapid symptom relief, but contemporary reviews highlight cautious use because systemic NSAIDs carry gastrointestinal, renal and cardiovascular harms, especially at higher doses or with longer use.

Comparative data indicate indomethacin, naproxen and celecoxib have broadly comparable efficacy for gout, with different safety profiles to consider when choosing therapy.

• Clinical pointers: Use the lowest effective dose for the shortest necessary duration.
• Monitor high‑risk patients closely and consider alternatives for those with significant comorbidities.

Alternatives Matrix

PBS‑Listed Alternatives Comparison Table

Pros And Cons Checklist

• Topical diclofenac — pros: lower systemic GI risk; cons: limited to localised applications.
• Naproxen — pros: effective for gout and inflammatory pain; cons: longer half‑life may increase accumulation in some patients.
• Celecoxib — pros: reduced GI ulcer risk for some patients; cons: selective COX‑2 agents require CV risk assessment.
• Decision checklist for clinicians: indication, comorbidities, concurrent medicines, patient preferences, PBS cost sensitivity, and monitoring plan.

Common Questions

• “Can I take other painkillers?” — Avoid taking other NSAIDs at the same time; paracetamol (acetaminophen) is often the preferred additive analgesic when needed.
• “How long can I safely take it?” — Use the shortest effective time; chronic use requires regular review and monitoring of renal, liver and blood pressure.
• “Can kids use it?” — Not routine; paediatric use is specialist‑led and weight‑based for selected conditions.
• “What are the red flags?” — Black or tarry stools, severe abdominal pain, sudden shortness of breath, marked reduction in urine output or jaundice; seek urgent care.
• Consider placing these as micro‑FAQ cards on clinic and pharmacy pages for quick access.

Price & Access Comparison Table

Prices for indomethacin products vary across pharmacies and over time; live price checks are recommended.

Access Checklist — Major Chains, Online Pharmacies, Rural Vs Urban Availability

• Confirm PBS eligibility and any authority requirements before filling a prescription.
• Ask your pharmacist about generics and therapeutic equivalents to manage cost.
• Request mail‑order or rural pharmacy networks if local stock is limited.
• Verify e‑prescription acceptance when ordering online.
• Avoid unregulated overseas suppliers that do not require prescriptions or accreditation.

Registration & Regulation

TGA Approval

• Indomethacin is subject to TGA oversight in Australia and is classified as a prescription medicine.
• Check the TGA online database for product registration details and the current Product Information for Australian‑specific indications.
• Hospital IV formulations may be restricted to inpatient or specialist use.

PBS Subsidy Details

• PBS listings change over time; consult the PBS Schedule for current subsidy status and any authority prescribing requirements.
• Contact a pharmacist for help with PBS questions and to check whether a given formulation qualifies for subsidy.
• For up‑to‑date registration and subsidy information, consult the TGA and PBS websites or speak to your pharmacist.

Storage & Handling

Household Storage In Australian Climate (Heat/Humidity)

Store indomethacin formulations below 30°C and protect them from moisture and direct sunlight.

Do not freeze the oral suspension and keep suppositories away from temperatures exceeding 40°C to avoid melting.

In hot Australian summers, avoid leaving medicines in cars or in direct sunlight and use a cool, dry storage area in the home.

Use a household medicine checklist to keep track of expiry dates and storage locations.

Cold‑Chain Handling For Pharmacies

• Follow TGA and manufacturer guidance for transport and storage of temperature‑sensitive products.
• Record batch numbers, expiry dates and storage logs where refrigeration or protected storage is specified.
• Handle injectable lyophilised vials according to manufacturer reconstitution instructions to preserve potency.

Guidelines For Proper Use (Australian Pharmacist Counselling Style)

Pharmacist Counselling Checklist

• Confirm the indication and the exact dose prescribed before supply.
• Review allergies and any previous NSAID reactions.
• Check the patient’s current medicines, especially anticoagulants, lithium, methotrexate, ACE inhibitors and diuretics.
• Advise taking indomethacin with food or milk to reduce dyspepsia.
• Discuss warning signs of serious adverse events such as gastrointestinal bleeding, reduced urine output, shortness of breath or chest pain.
• Arrange baseline renal function and LFTs for patients likely to use the medicine longer term.
• Document counselling and report suspected adverse events to the TGA adverse event reporting system.
• Emphasise non‑pharmacological measures such as rest, ice, physiotherapy referral and weight management where relevant.

Patient Advice From PBS And National Health Authorities

• Direct patients to authoritative resources such as the TGA, PBS and NPS MedicineWise for up‑to‑date consumer information.
• Advise follow‑up with the GP within 1–4 weeks of starting a new NSAID and sooner if adverse symptoms appear.
• Emergency advice: for overdose or severe reaction call 000 or present to the nearest emergency department.
• For suspected poisoning or toxicity contact the Poisons Information Centre on 13 11 26.

Suggested patient handout content: indication, dose, common side effects, red flags, when to stop, storage, and follow‑up plan.

Delivery Across Australia